[HTML][HTML] A randomized phase III study of short-course radiotherapy combined with Temozolomide in elderly patients with newly diagnosed glioblastoma; Japan clinical …

Y Arakawa, K Sasaki, Y Mineharu, M Uto, T Mizowaki… - BMC cancer, 2021 - Springer
Background The current standard treatment for elderly patients with newly diagnosed
glioblastoma is surgery followed by short-course radiotherapy with temozolomide. In recent …

A randomized phase III study of short-course radiotherapy combined with Temozolomide in elderly patients with newly diagnosed glioblastoma; Japan clinical …

Y Arakawa, K Sasaki, Y Mineharu, M Uto, T Mizowaki… - BMC Cancer, 2021 - europepmc.org
Background The current standard treatment for elderly patients with newly diagnosed
glioblastoma is surgery followed by short-course radiotherapy with temozolomide. In recent …

A randomized phase III study of short-course radiotherapy combined with Temozolomide in elderly patients with newly diagnosed glioblastoma; Japan clinical …

Y Arakawa, K Sasaki, Y Mineharu, M Uto… - BMC …, 2021 - pubmed.ncbi.nlm.nih.gov
Background The current standard treatment for elderly patients with newly diagnosed
glioblastoma is surgery followed by short-course radiotherapy with temozolomide. In recent …

[HTML][HTML] A randomized phase III study of short-course radiotherapy combined with Temozolomide in elderly patients with newly diagnosed glioblastoma; Japan clinical …

Y Arakawa, K Sasaki, Y Mineharu, M Uto… - BMC Cancer, 2021 - ncbi.nlm.nih.gov
Background The current standard treatment for elderly patients with newly diagnosed
glioblastoma is surgery followed by short-course radiotherapy with temozolomide. In recent …

A randomized phase III study of short-course radiotherapy combined with Temozolomide in elderly patients with newly diagnosed glioblastoma; Japan clinical …

Y Arakawa, K Sasaki, Y Mineharu, M Uto… - BMC …, 2021 - search.proquest.com
Background The current standard treatment for elderly patients with newly diagnosed
glioblastoma is surgery followed by short-course radiotherapy with temozolomide. In recent …

A randomized phase III study of short-course radiotherapy combined with Temozolomide in elderly patients with newly diagnosed glioblastoma; Japan clinical …

Y Arakawa, K Sasaki, Y Mineharu, M Uto… - BMC …, 2021 - repository.kulib.kyoto-u.ac.jp
BACKGROUND: The current standard treatment for elderly patients with newly diagnosed
glioblastoma is surgery followed by short-course radiotherapy with temozolomide. In recent …

[HTML][HTML] A randomized phase III study of short-course radiotherapy combined with Temozolomide in elderly patients with newly diagnosed glioblastoma; Japan clinical …

Y Arakawa, K Sasaki, Y Mineharu, M Uto… - BMC …, 2021 - bmccancer.biomedcentral.com
The current standard treatment for elderly patients with newly diagnosed glioblastoma is
surgery followed by short-course radiotherapy with temozolomide. In recent studies, 40 Gy in …

A randomized phase III study of short-course radiotherapy combined with Temozolomide in elderly patients with newly diagnosed glioblastoma; Japan clinical …

荒川, 芳輝, 峰晴, 宇藤恵, 溝脇, 尚志, 小野 - BMC Cancer, 2021 - cir.nii.ac.jp
BACKGROUND: The current standard treatment for elderly patients with newly diagnosed
glioblastoma is surgery followed by short-course radiotherapy with temozolomide. In recent …

A randomized phase III study of short-course radiotherapy combined with Temozolomide in elderly patients with newly diagnosed glioblastoma; Japan clinical …

Y Arakawa, K Sasaki, Y Mineharu, M Uto, T Mizowaki… - BMC Cancer, 2021 - go.gale.com
Background The current standard treatment for elderly patients with newly diagnosed
glioblastoma is surgery followed by short-course radiotherapy with temozolomide. In recent …